|
|
Go Beyond Lipid Management to
Improve Risk Prediction with Cardio CRP™ |
|
|
|
A powerful predictor of
first and recurrent cardiovascular events
|
Clinical
Background
| • |
Inflammation
plays a role in the initiation and progression of
atherosclerosis, the chief underlying cause of Myocardial
Infarction (MI)1 |
| • |
Cardio CRP
detects CRP levels as low as ~0.175 mg/L (standard CRP assays
cannot detect CRP levels <3.0 mg/L) |
| • |
Cardio CRP, a
sensitive marker of systemic inflammation, has emerged as a
powerful predictor of cardiovascular diseases, particularly of
coronary heart disease (CHD)2 |
Cardio
CRP (High Sensitivity C-Reactive Protein) is a Powerful Predictor of
First and Recurrent Cardiovascular Events
| • |
Cardio CRP
helps identify patients at risk of first MI even with
low-to-moderate risk lipid levels3 |
| • |
Cholesterol
screening fails to identify almost one-half of the 1.3 million
individuals who develop MI4 |
| • |
Adding Cardio
CRP to standard lipid screening significantly improves risk
prediction5 |
Cardio
CRP is an Indispensable Marker Revealing Life-Threatening Cardiovascular
Risk
| • |
Studies have
shown that the combination of Cardio CRP with the Total
Cholesterol: HDL-Cholesterol ratio is the strongest independent
predictor of peripheral artery disease1 |
| • |
Reveals risk
of future myocardial infarction and stroke among apparently
healthy men and women, independent of traditional risk factors6 |
| • |
Cardio CRP
appears to be an excellent marker of persistent plaque
instability7 |
| • |
Recent evidence shows that
Cardio CRP can help assess risk in patients with unstable angina7 |
Beyond
MI Risk Assessment: Cardio CRP and Diabetes
| • |
Elevated Cardio
CRP found to be a powerful independent risk determinant in the
prediction of incident diabetes8 |
| • |
Presence of
elevated Cardio CRP supports a possible role for inflammation in
the pathogenesis of type 2 diabetes mellitus (DM)8 |
| • |
Inflammatory
markers, like Cardio CRP, might provide an adjunctive method for
early detection of risk for DM8 |
Cardio
CRP Significantly Improves Cardiovascular Risk Assessment
| • |
Reveals risk of
future myocardial infarction and stroke among apparently healthy
men and women, independent of traditional risk factors6 |
| • |
Helps assess
risk of recurrent cardiovascular events7 |
| • |
Identifies
patients at risk of first MI even with low-to-moderate risk
lipid levels1 |
| • |
Serves as a
powerful independent risk determinant in the prediction of
incident diabetes8 |
Cardio
CRP Specimen Requirements
| • |
1 mL room
temperature serum (0.5 mL minimum); refrigerated or frozen serum
also acceptable. Alternatively, heparin or EDTA plasma may be
submitted. |
|
Overnight
fasting prior to specimen collection is preferred to avoid
excess turbidity due to lipemia. Samples should be collected 2
or more weeks after resolution of any acute inflammatory
disease. |
| • |
Life of Sample
Stability Data:
Room: 2 days
Refrigerated: 1 week
Frozen: 3 months
|
Online
Resources for Healthcare Professionals
Online
Test Information for Your Patients
Your patients can learn about health conditions and laboratory tests in
our online Patient
Health Library. The library is founded on evidence-based
information, and includes topics such as:
References
1 Ridker PM, Glynn RJ, Hennekens CH. C-reactive
protein adds to the predictive value of total and HDL cholesterol in
determining risk of first myocardial infarction. Circulation
1998;97:2007-2011.
http://www.questdiagnostics.com/hcp/topics/cardiocrp/cardiocrp.html |